A1510Introduced in the General Assembly
Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.
Introduced by Roy Freiman, District 16
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Improves access to lower cost generic and biosimilar drugs and revises certain requirements regarding dispensing of biosimilar drugs by pharmacies.
Where it stands
Reported out of Assembly Comm. with Amendments, 2nd Reading
June 4, 2026
How did lawmakers vote?
General AssemblyStage: Assembly Financial Institutions and Insurance Committee: Reported with Amendments · June 4, 2026
12
Yes
0
No
2
Absent or Not Voting
14 assemblymembers recorded in this General Assembly vote. Colors show vote categories only, not whether a vote was good or bad.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
See how each assemblymember voted
| Assemblymember | District | Vote |
|---|---|---|
| Heather Simmons | 3 | Not Voting |
| Dan Hutchison | 4 | Yes |
| Balvir Singh | 7 | Yes |
| Gregory Myhre | 9 | Yes |
| Luanne Peterpaul | 11 | Yes |
| Robert Clifton | 12 | Not Voting |
| Victoria Flynn | 13 | Yes |
| Roy Freiman | 16 | Yes |
| Sterley Stanley | 18 | Yes |
| Ed Rodriguez | 20 | Yes |
Bill history
Introduced, Referred to Assembly Financial Institutions and Insurance Committee
Reported out of Assembly Comm. with Amendments, 2nd Reading
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.